Eden Innovations (ASX:EDE): US Sales Update Highlights OptiBlend and EdenCrete Activity

Aditi Sarkar

06 October 2026 08:13 PM AEDT

Eden Innovations (ASX:EDE): US Sales Update Highlights OptiBlend and EdenCrete Activity

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

US Revenue for the quarter ended 30 September 2026 was US$381,612 (A$549,521).
OptiBlend generated US$259,863 (A$374,203) from nine unit orders during the quarter.
EdenCrete products contributed US$121,749 (A$175,319), including sales from the Pz7 product line.
Six new bulk storage and dispensing plants were installed in the United States during the quarter.
The company also reported a pipeline of OptiBlend quotations and further planned installations.

Eden Innovations Ltd (ASX:EDE) develops, manufactures and markets EdenCrete concrete admixtures and OptiBlend retrofit dual-fuel systems for diesel generator sets. Its latest US sales update covers the quarter from 1 July to 30 September 2026 and outlines revenue generated across both product lines, alongside installation activity and commercial quotations that may shape future operating updates.

Quarterly US Revenue Mix

Eden reported total US revenue of US$381,612 (A$549,521) for the first quarter of FY27. The company used an Exchange Rate of A$1.44 per US$1.00 for the Australian-dollar figures. OptiBlend accounted for US$259,863 (A$374,203) from nine unit orders, while EdenCrete products generated US$121,749 (A$175,319). Within the EdenCrete total, Pz7 sales were US$75,770 (A$109,109). The figures show that both operating product lines contributed to the quarter, with OptiBlend representing the larger portion of reported US revenue.

OptiBlend Orders and Quotation Activity

OptiBlend is designed to allow conventional diesel engines to use Natural Gas as a primary fuel without modifying the existing diesel fuel system. During the quarter, Eden reported 19 new OptiBlend quotations with a combined value of US$1,067,329 across several markets. The company also recorded a first shipment to Brazil of about US$26,000 and said two OptiBlend units valued at about US$110,000 were planned for installation in October 2026. Quotations represent potential Business rather than confirmed revenue, so future sales will depend on customer decisions and project timing.

EdenCrete Installation Footprint

Eden reported 32 bulk storage and dispensing sites across its network. In the United States, the company identified 21 sites, including 13 operational Pz7 plants, two additional plants pending in October 2026 and six original EdenCrete plants. Two Pz7 plants were located in Canada and nine in Ecuador. Six new plants were installed during the quarter, comprising three in Colorado, two in Texas and one in Minnesota. Eden said each plant is expected to generate between US$40,000 and US$80,000 in annual revenue when operating at full capacity, although the update did not specify when individual plants may reach that level.

What the Update Does and Does Not Show

The announcement is a sales update rather than a full set of financial statements. It does not provide profit, Margin or cash-flow figures for the quarter, and it does not provide guidance for the following quarter. Revenue connected with pending installations, quotations or trials should therefore be distinguished from revenue already reported. The company also noted further international activity across its product lines, but commercial outcomes will depend on customer adoption, installation timing and completion of individual projects.

Key Insights

Eden Innovations entered FY27 with revenue contributions from both OptiBlend and EdenCrete in the United States, alongside a larger physical installation base for its concrete-additive products. The quarter also included additional OptiBlend quotations and scheduled installations, providing measurable commercial activity without establishing future revenue certainty. Subsequent company updates will provide further information on order conversion, plant utilisation and the contribution of these products to broader financial performance.

FAQs

Q:What did Eden Innovations report for US revenue in Q1 FY27?

A:The company reported US revenue of US$381,612 (A$549,521) for the quarter ended 30 September 2026.

Q:How much revenue came from OptiBlend?

A:OptiBlend generated US$259,863 (A$374,203) from nine unit orders during the quarter.

Q:What did EdenCrete contribute?

A:EdenCrete products generated US$121,749 (A$175,319), including US$75,770 (A$109,109) from Pz7.

Q:How many new plants were installed during the quarter?

A:Six new plants were installed in the United States: three in Colorado, two in Texas and one in Minnesota.

Q:Are OptiBlend quotations counted as revenue?

A:No. Quotations represent potential customer activity and are not confirmed revenue until orders proceed and relevant sales are recognised.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.